Respiratory syncytial virus (RSV-) vaccine
Arexvy
Target group:
People aged 60 years and older who have active protection against RSV disease in the lower respiratory tract and people aged 50-59 years who are at increased risk of RSV disease.
Vaccination dose:
Single dose.
Protection duration:
It is not clear whether revaccination is needed.